Sign In
Buy GLP
$48.45
-0.81 (-1.64%)
At Close: Jun 03, 2026
GLP-1 Drug Development Market Pile-Up Continues
08:20am, Monday, 20'th May 2024
The mean weight loss in a Phase 1b trial of the GLP/GIP against CT-388 (once-a-week injection for 24 weeks) has just read out at 18.8%, with (apparently) no safety signals. Amgen sort-of-announced pos
Thomson Reuters Co. (NYSE:TRI) Shares Sold by Beacon Pointe Advisors LLC
07:32am, Monday, 20'th May 2024
Beacon Pointe Advisors LLC lessened its position in shares of Thomson Reuters Co. (NYSE:TRI – Free Report) (TSE:TRI) by 2.9% during the fourth quarter, according to the company in its most recen
Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% (p
Q2 2024 EPS Estimates for Cresco Labs Inc. (OTCMKTS:CRLBF) Boosted by Alliance Global Partners
01:38am, Monday, 20'th May 2024
Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Analysts at Alliance Global Partners increased their Q2 2024 earnings per share (EPS) estimates for Cresco Labs in a research note issued o
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT May 19, 2024 12:50 PM EDT | Source: The Rosen Law
Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study
09:10am, Friday, 17'th May 2024
Study WEIGHT-A24-1 will evaluate DehydraTECH-processed pure semaglutide and liraglutide Will DehydraTECH processing result in higher brain absorption of GLP-1 drugs? KELOWNA, BC / ACCESSWIRE / May 17,
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
08:24am, Friday, 17'th May 2024
Wegovy and Zepbound are two of the hottest GLP-1 drugs available on the market right now. The field, however, could become more crowded as more companies develop rival treatments.
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity
01:10am, Thursday, 16'th May 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase Ib clinical trial of CT-388, a dual G
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
02:35pm, Tuesday, 14'th May 2024
A wide swath of Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind's new AI model can predict the structure of molecules.
Global Partners LP Common Units (GLP) Q1 2024 Earnings Call Transcript
01:09pm, Wednesday, 08'th May 2024
Global Partners LP Common Units (NYSE:GLP ) Q1 2024 Earnings Conference Call May 8, 2024 10:00 AM ET Company Participants Sean Geary - CLO & Secretary Eric Slifka - President & CEO Gregory Hanson - CF
Global Partners LP Reports First-Quarter 2024 Financial Results
08:00am, Wednesday, 08'th May 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (“Global” or the “Partnership”) today reported financial results for the first quarter ended March 31, 2024. CEO Commentary Eric
What Will Global Partners' (GLP) Q1 Earnings Unveil?
09:36am, Monday, 06'th May 2024
Global Partners (GLP) beat the Zacks Consensus Estimate for earnings in two of the last four quarters and missed in the other two, resulting in an earnings surprise of 5.9%, on average.
Global Partners LP (GLP) Rises As Market Takes a Dip: Key Facts
07:16pm, Wednesday, 01'st May 2024
Global Partners LP (GLP) reachead $46.96 at the closing of the latest trading day, reflecting a +0.15% change compared to its last close.
Global Partners LP (GLP) Rises As Market Takes a Dip: Key Facts
07:21pm, Thursday, 25'th Apr 2024
In the closing of the recent trading day, Global Partners LP (GLP) stood at $47.33, denoting a +1.39% change from the preceding trading day.
Global Partners Declares First-Quarter 2024 Cash Distribution of $0.7100 on Common Units
08:30am, Thursday, 25'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (the “Partnership”) today announced that the Board of Directors of its general partner, Global GP LLC, has declared a cash distribut
